Rosskamp R - Search Results

1

PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.

Baum MA, Langman C, Cochat P, Lieske JC, Moochhala SH, Hamamoto S, Satoh H, Mourani C, Ariceta G, Torres A, Wolley M, Belostotsky V, Forbes TA, Groothoff J, Hayes W, Tönshoff B, Takayama T, Rosskamp R, Russell K, Zhou J, Amrite A, Hoppe B; PHYOX2 study investigators. Baum MA, et al. Among authors: rosskamp r. Kidney Int. 2023 Jan;103(1):207-217. doi: 10.1016/j.kint.2022.07.025. Epub 2022 Aug 22. Kidney Int. 2023. PMID: 36007597 Free article. Clinical Trial.

2

Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.

Ariceta G, Barrios K, Brown BD, Hoppe B, Rosskamp R, Langman CB. Ariceta G, et al. Among authors: rosskamp r. Kidney Int Rep. 2021 Feb 3;6(4):1088-1098. doi: 10.1016/j.ekir.2021.01.029. eCollection 2021 Apr. Kidney Int Rep. 2021. PMID: 33912759 Free PMC article.

3

End Points for Clinical Trials in Primary Hyperoxaluria.

Milliner DS, McGregor TL, Thompson A, Dehmel B, Knight J, Rosskamp R, Blank M, Yang S, Fargue S, Rumsby G, Groothoff J, Allain M, West M, Hollander K, Lowther WT, Lieske JC. Milliner DS, et al. Among authors: rosskamp r. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1056-1065. doi: 10.2215/CJN.13821119. Epub 2020 Mar 12. Clin J Am Soc Nephrol. 2020. PMID: 32165440 Free PMC article.

4

Serum vitamin D metabolites do not change in response to intravenous injection of thyrotropin releasing hormone (TRH) and growth hormone releasing factor (GHRF 1-44) in children.

Rosskamp R, Issa S, Burmeister W. Rosskamp R, et al. J Endocrinol Invest. 1988 Jan;11(1):27-30. doi: 10.1007/BF03350090. J Endocrinol Invest. 1988. PMID: 3129486

5

Effect of insulin-induced hypoglycemia on circulating levels of plasma growth hormone-releasing hormone and somatostatin in children.

Rosskamp R, Becker M, Tegeler A, Klumpp J. Rosskamp R, et al. Horm Res. 1987;27(3):121-5. doi: 10.1159/000180799. Horm Res. 1987. PMID: 2891599

6

[Idiopathic juvenile osteoporosis--report of 2 cases].

Rosskamp R, Sell G, Emons D, Issa S, Burmeister W. Rosskamp R, et al. Klin Padiatr. 1987 Nov-Dec;199(6):457-61. doi: 10.1055/s-2008-1026840. Klin Padiatr. 1987. PMID: 3431025 German.

7

Rapid effect of intravenous growth hormone (GH)-releasing hormone 1-44 on plasma GH levels in children.

Rosskamp R, Haverkamp F. Rosskamp R, et al. Eur J Pediatr. 1988 Oct;148(1):17-8. doi: 10.1007/BF00441805. Eur J Pediatr. 1988. PMID: 3143592

8

[Growth hormone releasing hormone. Review].

Rosskamp R. Rosskamp R. Klin Padiatr. 1988 Mar-Apr;200(2):81-8. doi: 10.1055/s-2008-1033691. Klin Padiatr. 1988. PMID: 3133522 Review. German.

9

Plasma levels of growth hormone-releasing hormone and somatostatin in response to a mixed meal and during sleep in children.

Rosskamp R, Becker M, Haverkamp F, Thomas B, Brühl S, Klumpp J, Liappis N. Rosskamp R, et al. Acta Endocrinol (Copenh). 1987 Dec;116(4):549-54. doi: 10.1530/acta.0.1160549. Acta Endocrinol (Copenh). 1987. PMID: 2892332

10

[Thiamine-dependent anemia and thrombocytopenia, insulin-dependent diabetes mellitus and sensorineural deafness--case report and review].

Rosskamp R, Zigrahn W, Burmeister W. Rosskamp R, et al. Klin Padiatr. 1985 Jul-Aug;197(4):315-7. doi: 10.1055/s-2008-1033992. Klin Padiatr. 1985. PMID: 4046487 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page